Navigation Links
Frost & Sullivan Examines the Key Challenges in the European Non-Invasive Ventilation Market
Date:7/21/2009

LONDON, July 21 /PRNewswire/ -- Europe's aging population has led to a rise in the number of registrations and diagnoses of respiratory diseases. While there has been a shift towards non-invasive ventilation to manage these diseases, manufacturers are struggling to maintain profit margins in this highly price sensitive market, while providing technologically advanced products at the same time.

(Logo:http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

To provide decision makers with key insights into the European non-invasive ventilation market, the Healthcare Group at Frost & Sullivan will be hosting an online analyst briefing presentation on Wednesday 29 July 2009, at 4 p.m. BST. The briefing will benefit manufacturers and distributors of non-invasive ventilation devices and accessories in Europe.

"The quality of service and after-sales support provided by the manufacturer is an important criterion for the end-user, when it comes to making a choice between different ventilator manufacturers," says Frost & Sullivan Research Analyst Akanksha Joshi. "Manufacturers who offer bundling and flexible service contracts will therefore have an edge over their competitors."

To participate in this briefing, please email Patrick Cairns at patrick.cairns@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. Upon receipt of the above information, a registration link will be emailed to you.

About Frost & Sullivan:

Frost & Sullivan, the Growth Partnership Company, partners with clients
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Frost & Sullivan Examines the Key Challenges in the European Non-Invasive Ventilation Market
2. Growth in African Medical Imaging Markets: Frost & Sullivan Examines the Potential
3. Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders, Advises Frost & Sullivan
4. Frost & Sullivan Lauds Marigot Ltd. and GTC Nutrition for Their Innovative CalciLife(TM)
5. Frost & Sullivan Identifies Innovative and Cost-Effective Technology as Key Competitive Factor in European Medical Device Market
6. Dual Frost & Sullivan Accolade for Veolia Water Solutions & Technologies
7. APAC Sensors Market Likely to be Driven by Medical and Process Industries in 2009, Says Frost & Sullivan
8. Multiple Advantages to Boost Deployment of Wireless and Handheld Devices in Healthcare, States Frost & Sullivan
9. Frost & Sullivan European Gastroenterology Technology Implementation of the Year Award Bestowed on Crospon
10. Cellular Technology Extends the Boundaries of E-healthcare, Says Frost & Sullivan
11. Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market, States Frost & Sullivan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...toImproveOverallOutcomesforLungCancer ,, WASH...CancerAlliance-California(LCA-CA)issuedits2ndAnnua...essmentofprogressbeingmadeagainstthislethaldisease...rAlliance(LCA),theonlynationalorganizationdedicate...vingwithoratriskforlungcancer. ,, (Photo: http:...
(Date:11/25/2009)... and Spanish . , , Researchers from the ...gnosis of certain ocular diseases that are very co...on and keratitis, by applying an existing optical ...n used for this purpose. , Scientists from the ...fected by one of these two pathologies, finding a ...
(Date:11/25/2009).... Kaplan, MD, FACP, a former Board Chair and one o...me Los Angeles Biomedical Research Institute at Ha...red by the American College of Physicians for his ...its April 22, 2010 meeting in Toronto, the America...th the Ralph O. Claypoole Sr. Memorial Award for D...
(Date:11/25/2009)... . , An innovative treatment for HIV patient...earchers has passed its first clinical trial with ...py customized for each individual patient, and was...titute of the MUHC in collaboration with Dr. R. Sk...ine made for the individual patient an "haute cou...
(Date:11/25/2009)...o new drugs for people, researchers say , ...dienes, natural lipid molecules found in soy, coul...cancer, California researchers have found. , T... pointed out that they could help explain why soy ..., In the study, Dr. Julie Saba, senior scientis...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2Health News:Achieve early diagnosis of ocular pathologies such as keratitis and macular degeneration 2Health News:1 of LA BioMed's founders to be honored 2Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Natural Soy Component May Help Treat Colon Cancer 2
...rs could provide scientific baseline for anti-agin...ov. 19 (HealthDay News) -- Genetic biomarkers that...age have been identified by researchers at Califor...ode worms, microarrays that measure changes in gen...
... Cancer Society urges people to stop for a day, th...Day News) -- Everyone knows smoking is bad for you...rs for Disease Control and Prevention said that th...h levels of smoking-related health problems, death...
...E, Calif., Nov. 19 Accuray Incorporated,(Nasdaq: ...gery, announced today,that on November 14, 2008, t...,Market stating that it is not in compliance with ...2008. , Within 60 calendar days following re...
...ve approach could aid research, treatment, experts...s) -- U.S. researchers say they,ve developed a new...urvival of cancer-killing cells within the body. ,...m Stanford University School of Medicine reports. ...
... Tenn., Nov. 19 Arabesque, an imprint of Kimani P...00 to St. Jude Children,s Research Hospital(R) in ...ove & Hope. The donation was presented recentl...thors Sandra Kitt and Gwynne Forster attended to a...
...kthrough Technology Leaves Skin Consistently Smoot... 18 Body-sculpting technology with consistently s... has launched in the U.S. and is now available to ...po is a laser device for minimally invasive laser-...
Other Medicine News:Health News:Researchers ID Suite of Genes in Aging Process 2Health News:Smokeout '08: The Perfect Time to Quit 2Health News:Smokeout '08: The Perfect Time to Quit 3Health News:Smokeout '08: The Perfect Time to Quit 4Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 2Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 3Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 4Health News:Technique Tracks Cancer-Killing Cells 2Health News:Arabesque Books Donates $15,000 in Support of St. Jude in Conjunction With a New Fall Book Series 2Health News:Eleme Medical Launches SmoothLipo(TM) Body Shaping Treatment 2
(Date:11/25/2009)...FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalpro...ssystems,announcedtodaythatClintSeverson,chairmana...PiperJaffrayHealthCareConferenceonWednesday,Decemb...ewYorkPalaceHotelinNewYorkCity. ,, AboutAbaxis...blebloodanalysissystemsforuseinanyveterinaryorhuma...
(Date:11/25/2009)...l/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicecom...ivesurgicaltreatmentsforthespine,announcedtodaytha...,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfocu...ny,sproductsandwillincludecommentsfrommanagementfo...umbersare1-877-407-4018fordomesticcallersand1-201-...
(Date:11/25/2009)...inker.comannouncesthatanewmarketresearchreportisav...ry-USMarketTrends&Analysis http://www.reportl...arket-Trends--Analysis.html ,, TheUSintranasal...uticapplicationsfromthedeliveryofconventionallocal...drugs.Thefutureofthetechnologyhingesontotheeffecti...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5IncentOne Announces New Incentive Wrap Around to Increase Participation in Multi Flu Prevention Programs 52262 1IncentOne Announces New Incentive Wrap Around to Increase Participation in Multi Flu Prevention Programs 52262 2First Anniversary of New War on Cancer Marks Many Advances 52259 1First Anniversary of New War on Cancer Marks Many Advances 52259 2First Anniversary of New War on Cancer Marks Many Advances 52259 3First Anniversary of New War on Cancer Marks Many Advances 52259 4First Anniversary of New War on Cancer Marks Many Advances 52259 5First Anniversary of New War on Cancer Marks Many Advances 52259 6First Anniversary of New War on Cancer Marks Many Advances 52259 7Anti epilepsy drug risk on cognitive function for unborn children 52256 1Anti epilepsy drug risk on cognitive function for unborn children 52256 2
...th ("Radius"),announced today that the company has...s internal nonsteroidal selective androgen recepto...reclinical development as a,potential therapy for ...ia),and other musculoskeletal conditions such as o...of promising SARMs after it demonstrated exception...
...peutics,Inc. (Nasdaq: HALO ), a biopharmaceutical...argeting the extracellular matrix, today,announced...tus program at,the American Diabetes Association,s...mbining the company,s proprietary recombinant huma... (regular insulin human) or,Humalog(R) (insulin li...
Other Medicine Technology:Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 3Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 4Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 5
Optima 38/SP
Optima FW
Hertel
Exophthalmometer, Hertel
Medicine Products: